Exhibitions and events
List of headings :
JED nBISE 2025
 |
Press Release: Oncomedics Awarded France 2030 Plan Grant
Limoges, March 14, 2025 – Oncomedics, a biotechnology company specializing in the personalization of cancer treatments and a member of the Oncomedics Group, has been named a laureate of the France 2030 Plan under the "Industrialization and Health Capacities 2030" call for projects. This second distinction, following its recognition under the France Relance program in 2021, will enable the large-scale industrialization of its innovative medical device: the Oncogramme®.
|
Partnership between Eurofins Biomnis and Oncomedics
Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.
|
Press release : Oncomedics joins Oncomedics Group
Oncomedics Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.
|